CN107874239A - A kind of double Gly-His-Lys of double mushrooms for preventing lesion tissue - Google Patents
A kind of double Gly-His-Lys of double mushrooms for preventing lesion tissue Download PDFInfo
- Publication number
- CN107874239A CN107874239A CN201711099186.0A CN201711099186A CN107874239A CN 107874239 A CN107874239 A CN 107874239A CN 201711099186 A CN201711099186 A CN 201711099186A CN 107874239 A CN107874239 A CN 107874239A
- Authority
- CN
- China
- Prior art keywords
- parts
- double
- lys
- gly
- mushrooms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000001674 Agaricus brunnescens Nutrition 0.000 title claims abstract description 53
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 title claims abstract description 33
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 title claims abstract description 33
- 230000003902 lesion Effects 0.000 title claims abstract description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 40
- 239000000843 powder Substances 0.000 claims abstract description 23
- 229920001202 Inulin Polymers 0.000 claims abstract description 21
- 239000004376 Sucralose Substances 0.000 claims abstract description 21
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 21
- 229940029339 inulin Drugs 0.000 claims abstract description 21
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims abstract description 21
- 235000019408 sucralose Nutrition 0.000 claims abstract description 21
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 20
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 20
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 20
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 20
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 20
- 239000011718 vitamin C Substances 0.000 claims abstract description 20
- 241000209140 Triticum Species 0.000 claims abstract description 18
- 235000021307 Triticum Nutrition 0.000 claims abstract description 18
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000010931 gold Substances 0.000 claims abstract description 18
- 229910052737 gold Inorganic materials 0.000 claims abstract description 18
- 240000008042 Zea mays Species 0.000 claims abstract description 17
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 17
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 16
- 235000005822 corn Nutrition 0.000 claims abstract description 16
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims 1
- 235000009973 maize Nutrition 0.000 claims 1
- 230000036039 immunity Effects 0.000 abstract description 7
- 230000006378 damage Effects 0.000 abstract description 4
- 235000015250 liver sausages Nutrition 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 210000001519 tissue Anatomy 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 8
- 239000011812 mixed powder Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 235000014347 soups Nutrition 0.000 description 7
- 239000003814 drug Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000700605 Viruses Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of double Gly-His-Lys of double mushrooms for preventing lesion tissue in health care pharmaceutical technology field, at least it is made up of following components：The oligomeric Gly-His-Lys of inulin, Shitake Mushroom P.E, gold needle mushroom extract, corn oligopeptide powder, wheat, vitamin C, Sucralose.The experiment proved that, can effectively the cell of repairing damage, prevention lesion tissue, enhancing body immunity, ensure liver sausage function, have no side effect to human body.
Description
Technical field
The present invention relates to health care pharmaceutical technology field, the double Gly-His-Lys of more particularly to a kind of double mushrooms.
Background technology
With the quickening pace of modern life, P greatly increases.In order to prevent P, people start to focus in advance
It is anti-, wherein, it is an optimal approach to take health care medicine.But the good and bad jumbled together in the market health products, nutrition-allocated proportion combination
It is very various, therefore a kind of, it is necessary to health care medicine for having no side effect to human body, can also strengthening body immunity.
The content of the invention
It is an object of the invention to provide a kind of double Gly-His-Lys of double mushrooms for preventing lesion tissue, effective repairing damage it is thin
Born of the same parents, prevention lesion tissue, enhancing body immunity.
The object of the present invention is achieved like this：A kind of double Gly-His-Lys of double mushrooms for preventing lesion tissue, it is characterised in that：Extremely
It is few to be made up of following components：The oligomeric Gly-His-Lys of inulin, Shitake Mushroom P.E, gold needle mushroom extract, corn oligopeptide powder, wheat, dimension life
Plain C, Sucralose.
Preferably, at least it is made up of the component of following parts by weight：Inulin 38-42 parts, Shitake Mushroom P.E 14-16
Part, gold needle mushroom extract 13-16 parts, corn oligopeptide powder 14-17 parts, the oligomeric Gly-His-Lys 13-17 parts of wheat, vitamin C 0.45-
0.49 part, Sucralose 0.02-0.025 parts.
As further preferred scheme, at least it is made up of the component of following parts by weight：40 parts of inulin, Shitake Mushroom P.E 15
Part, 15 parts of gold needle mushroom extract, 15 parts of corn oligopeptide powder, 15 parts of the oligomeric Gly-His-Lys of wheat, 0.48 part of vitamin C, Sucralose
0.024 part.
Compared with prior art, the beneficial effects of the present invention are：First, corn oligopeptide powder contains abundant side chain ammonia
Base acid --- leucine, isoleucine and valine, the hepatic injury caused by all reasons can be repaired, the oligomeric Gly-His-Lys of wheat contain
Abundant glutamine, the intestinal mucosa of energy repairing damage, above-mentioned two plant peptide have good strengthen immunity, antioxygen
Change, be antifatigue, suppressing ACE enzymes and reach aided blood pressure-lowering, the auxiliary hyperglycemic for promoting insulin secretion to reach etc. physiology and live
Property；Secondly, the fungi polysaccharide that Shitake Mushroom P.E and gold needle mushroom extract contain can suppress growing for virus, emulative
Inhibit cell receptor to receive the performance of virus protein ability, virus is difficult to enter into the cell, can be direct by human body
Absorb, through cell participates in human life activity, rapidly and efficiently, the cell of effective repairing damage, prevention lesion tissue, increases
Strong body immunity.
Embodiment
Beneficial effects of the present invention are expanded on further below by experiment, the present invention is expanded on further by embodiment.
Embodiment 1
The double Gly-His-Lys of double mushrooms of lesion tissue can be prevented, each raw material weight proportioning of soup processed is as follows：38 parts of inulin, 14 parts of Shitake Mushroom P.E, gold
16 parts of pin mushroom extract, 17 parts of corn oligopeptide powder, 15 parts of the oligomeric Gly-His-Lys of wheat, 0.45 part of vitamin C, Sucralose 0.025
Part.
Its preparation process, comprises the following steps：
Weigh 38 parts of inulin, 14 parts of Shitake Mushroom P.E, 16 parts of gold needle mushroom extract, 17 parts of corn oligopeptide powder, wheat oligopeptide
15 parts of powder, 0.45 part of vitamin C, 0.025 part of Sucralose, mix to obtain total mixed powder；Pack 10g/ bags.
Embodiment 2
The double Gly-His-Lys of double mushrooms of lesion tissue can be prevented, each raw material weight proportioning of soup processed is as follows：42 parts of inulin, 16 parts of Shitake Mushroom P.E, gold
13 parts of pin mushroom extract, 14 parts of corn oligopeptide powder, 15 parts of the oligomeric Gly-His-Lys of wheat, 0.47 part of vitamin C, Sucralose 0.02
Part.
Its preparation process, comprises the following steps：
Weigh 42 parts of inulin, 16 parts of Shitake Mushroom P.E, 13 parts of gold needle mushroom extract, 14 parts of corn oligopeptide powder, wheat oligopeptide
15 parts of powder, 0.47 part of vitamin C, 0.02 part of Sucralose, mix to obtain total mixed powder；Pack 10g/ bags.
Embodiment 3
The double Gly-His-Lys of double mushrooms of lesion tissue can be prevented, each raw material weight proportioning of soup processed is as follows：40 parts of inulin, 15 parts of Shitake Mushroom P.E, gold
15 parts of pin mushroom extract, 15 parts of corn oligopeptide powder, 15 parts of the oligomeric Gly-His-Lys of wheat, 0.48 part of vitamin C, Sucralose 0.024
Part.
Its preparation process, comprises the following steps：
Weigh 40 parts of inulin, 15 parts of Shitake Mushroom P.E, 15 parts of gold needle mushroom extract, 15 parts of corn oligopeptide powder, wheat oligopeptide
15 parts of powder, 0.48 part of vitamin C, 0.024 part of Sucralose, mix to obtain total mixed powder；Pack 10g/ bags.
Comparative example 1
The double Gly-His-Lys of double mushrooms of lesion tissue can be prevented, each raw material weight proportioning of soup processed is as follows：40 parts of inulin, 30 parts of gold needle mushroom extract,
30 parts of corn oligopeptide powder, 0.48 part of vitamin C, 0.024 part of Sucralose.
Its preparation process, comprises the following steps：
Weigh 40 parts of inulin, 30 parts of gold needle mushroom extract, 30 parts of corn oligopeptide powder, 0.48 part of vitamin C, Sucralose
0.024 part, mix to obtain total mixed powder；Pack 10g/ bags.
Comparative example 2
The double Gly-His-Lys of double mushrooms of lesion tissue can be prevented, each raw material weight proportioning of soup processed is as follows：40 parts of inulin, 30 parts of Shitake Mushroom P.E are small
30 parts of the oligomeric Gly-His-Lys of wheat, 0.48 part of vitamin C, 0.024 part of Sucralose.
Its preparation process, comprises the following steps：
Weigh 40 parts of inulin, 30 parts of Shitake Mushroom P.E, 30 parts of the oligomeric Gly-His-Lys of wheat, 0.48 part of vitamin C, Sucralose 0.024
Part, mix to obtain total mixed powder；Pack 10g/ bags.
Comparative example 3
The double Gly-His-Lys of double mushrooms of lesion tissue can be prevented, each raw material weight proportioning of soup processed is as follows：40 parts of inulin, 30 parts of Shitake Mushroom P.E are beautiful
Oligomeric 30 parts of the Gly-His-Lys of rice, 0.48 part of vitamin C, 0.024 part of Sucralose.
Its preparation process, comprises the following steps：
Weigh 40 parts of inulin, 30 parts of Shitake Mushroom P.E, 30 parts of corn oligopeptide powder, 0.48 part of vitamin C, Sucralose 0.024
Part, mix to obtain total mixed powder；Pack 10g/ bags.
Comparative example 4
The double Gly-His-Lys of double mushrooms of lesion tissue can be prevented, each raw material weight proportioning of soup processed is as follows：40 parts of inulin, 30 parts of gold needle mushroom extract,
30 parts of the oligomeric Gly-His-Lys of wheat, 0.48 part of vitamin C, 0.024 part of Sucralose.
Its preparation process, comprises the following steps：
Weigh 40 parts of inulin, 30 parts of gold needle mushroom extract, 30 parts of the oligomeric Gly-His-Lys of wheat, 0.48 part of vitamin C, Sucralose
0.024 part, mix to obtain total mixed powder；Pack 10g/ bags.
Pharmacodynamic experiment
Experimental subjects
Body immunity is poor, is susceptible to suffer from that weakness type cold, deficiency of vital energy flu, liver sausage are abnormal, insufficiency of the spleen pond is rushed down, the people of palpitation due to deficiency of vital energy disorder 120,
Each 60 people of men and women, the age is between 60-70.
Curative effect determinate standard
" effective "：After treatment, cardinal symptom all disappears, clinical cure.
" effective "：Clinical symptoms before treatment than taking a turn for the better.
Engineering noise：Clinical symptom and sign is without improvement.
Treatment method
One time a day, every time 1 bag.
Blank control group：40 people, each half of men and women, when embodiment group and comparative example group take corresponding powder medicaments, drink white
Boiling water.
Comparative example group：160 people, edible comparative example 1-4 product, every group of 40 people, every group of each half of men and women, one time a day, often
Secondary 1 bag of powder medicaments for taking comparative example 1-4, are taken after mixing it with water with plain boiled water.
Embodiment group：120 people, edible embodiment 1-3 product, every group of 40 people, every group of each half of men and women, one time a day, often
Secondary 1 bag of powder medicaments for taking embodiment 1-3, are taken after mixing it with water with plain boiled water.
Result detection is carried out after 30 days to every group of experimental subjects.
Therapeutic effect
Treatment data statistics such as following table：
It can be obtained by upper table：The double Gly-His-Lys of double mushrooms of this formula significant effect in terms of lifting immunity, protection liver sausage function.
The invention is not limited in above-described embodiment, on the basis of technical scheme disclosed by the invention, the skill of this area
Art personnel are according to disclosed technology contents, it is not necessary to which performing creative labour can makes one to some of which technical characteristic
A little to replace and deform, these are replaced and deformation is within the scope of the present invention.
Claims (3)
- A kind of 1. double Gly-His-Lys of double mushrooms for preventing lesion tissue, it is characterised in that：At least it is made up of following components：Inulin, mushroom The oligomeric Gly-His-Lys of extract, gold needle mushroom extract, corn oligopeptide powder, wheat, vitamin C, Sucralose.
- A kind of 2. double Gly-His-Lys of double mushrooms for preventing lesion tissue according to claim 1, it is characterised in that：At least by following The component of parts by weight is made：Inulin 38-42 parts, Shitake Mushroom P.E 14-16 parts, gold needle mushroom extract 13-16 parts, maize oligopeptide Powder 14-17 parts, the oligomeric Gly-His-Lys 13-17 parts of wheat, vitamin C 0.45-0.49 parts, Sucralose 0.02-0.025 parts.
- A kind of 3. double Gly-His-Lys of double mushrooms for preventing lesion tissue according to claim 2, it is characterised in that：At least by following The component of parts by weight is made：40 parts of inulin, 15 parts of Shitake Mushroom P.E, 15 parts of gold needle mushroom extract, 15 parts of corn oligopeptide powder are small 15 parts of the oligomeric Gly-His-Lys of wheat, 0.48 part of vitamin C, 0.024 part of Sucralose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711099186.0A CN107874239A (en) | 2017-11-09 | 2017-11-09 | A kind of double Gly-His-Lys of double mushrooms for preventing lesion tissue |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711099186.0A CN107874239A (en) | 2017-11-09 | 2017-11-09 | A kind of double Gly-His-Lys of double mushrooms for preventing lesion tissue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107874239A true CN107874239A (en) | 2018-04-06 |
Family
ID=61779866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711099186.0A Pending CN107874239A (en) | 2017-11-09 | 2017-11-09 | A kind of double Gly-His-Lys of double mushrooms for preventing lesion tissue |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107874239A (en) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102885301A (en) * | 2012-09-19 | 2013-01-23 | 北京同仁堂健康药业股份有限公司 | Composition for enhancing immunity and preparation method thereof |
| CN103583941A (en) * | 2012-08-14 | 2014-02-19 | 黄庆禄 | Health-preserving oral liquid and preparation method thereof |
| CN104605353A (en) * | 2015-01-27 | 2015-05-13 | 南阳市新天地生物科技有限公司 | Formula food suitable for being eaten by tumor patients after operation and preparation method of formula food |
| CN104872679A (en) * | 2015-06-19 | 2015-09-02 | 福和寿（武汉）健康管理有限公司 | Health food capable of improving intestines and stomachs and enhancing immunity function and preparation method of food |
| CN105146260A (en) * | 2015-07-16 | 2015-12-16 | 广州施健生物科技有限公司 | Functional food facilitating recovery of gastric mucosal lesion |
| CN105211857A (en) * | 2015-09-30 | 2016-01-06 | 广州金酮医疗科技有限公司 | A kind of alimentation composition and uses thereof |
| CN105294877A (en) * | 2015-11-30 | 2016-02-03 | 中华全国供销合作总社济南果品研究院 | Method of extracting and purifying flammulina velutipes polysaccharide from flammulina velutipes or flammulina velutipes roots |
| CN106721851A (en) * | 2017-01-06 | 2017-05-31 | 唐山金鼎盛生物科技有限公司 | A kind of solid beverage of brand-new formula |
| CN107252114A (en) * | 2017-07-01 | 2017-10-17 | 马南行 | A kind of composition of strengthen immunity anti-aging and preparation method thereof |
-
2017
- 2017-11-09 CN CN201711099186.0A patent/CN107874239A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103583941A (en) * | 2012-08-14 | 2014-02-19 | 黄庆禄 | Health-preserving oral liquid and preparation method thereof |
| CN102885301A (en) * | 2012-09-19 | 2013-01-23 | 北京同仁堂健康药业股份有限公司 | Composition for enhancing immunity and preparation method thereof |
| CN104605353A (en) * | 2015-01-27 | 2015-05-13 | 南阳市新天地生物科技有限公司 | Formula food suitable for being eaten by tumor patients after operation and preparation method of formula food |
| CN104872679A (en) * | 2015-06-19 | 2015-09-02 | 福和寿（武汉）健康管理有限公司 | Health food capable of improving intestines and stomachs and enhancing immunity function and preparation method of food |
| CN105146260A (en) * | 2015-07-16 | 2015-12-16 | 广州施健生物科技有限公司 | Functional food facilitating recovery of gastric mucosal lesion |
| CN105211857A (en) * | 2015-09-30 | 2016-01-06 | 广州金酮医疗科技有限公司 | A kind of alimentation composition and uses thereof |
| CN105294877A (en) * | 2015-11-30 | 2016-02-03 | 中华全国供销合作总社济南果品研究院 | Method of extracting and purifying flammulina velutipes polysaccharide from flammulina velutipes or flammulina velutipes roots |
| CN106721851A (en) * | 2017-01-06 | 2017-05-31 | 唐山金鼎盛生物科技有限公司 | A kind of solid beverage of brand-new formula |
| CN107252114A (en) * | 2017-07-01 | 2017-10-17 | 马南行 | A kind of composition of strengthen immunity anti-aging and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 吴金鸿等: "《这样吃不生病：全民提升免疫力》", 31 October 2012, 中国医药科技出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105533380B (en) | A kind of Dealcoholic solid beverage and preparation method thereof | |
| CN103653147A (en) | Wheat peptide anti-fatigue health drink and preparation method thereof | |
| CN103549433A (en) | Traditional Chinese medicine health-care food with liver protecting effect | |
| CN102972843B (en) | Sea cucumber effervescent tablet and preparation technique thereof | |
| CN105360541A (en) | Candy with appetite stimulating and spleen strengthening effects and preparation method thereof | |
| CN104921099A (en) | Diabetes specific complex oligopeptide food and manufacturing method and application thereof | |
| TW201943417A (en) | Food composition for cognitive function improvement, cognitive function improving agent, and production method thereof characterized by containing L-ergothioneine as an active ingredient | |
| CN108740660A (en) | A kind of health drink and preparation method thereof improving immunity | |
| CN109567024A (en) | Black mulberries cereal nutrition bar of lycium ruthenicum and preparation method thereof | |
| CN107874239A (en) | A kind of double Gly-His-Lys of double mushrooms for preventing lesion tissue | |
| CN107212420A (en) | A kind of sturgeon air bladder polypeptide health care food for strengthening immunocompetence and preparation method thereof | |
| CN106387651A (en) | Eight-treasure porridge containing astaxanthin and making method thereof | |
| CN102783638A (en) | Mixed powder of Cordyceps sinensis fungal powder and American ginseng, and its preparation method | |
| CN105533714A (en) | Chinese herbal preparation with anti-alcohol and anti-fatigue effects and preparation method thereof | |
| CN104647881A (en) | Fruit juice milk tea with effects of dispelling effects of alcohol, protecting liver and nourishing stomach and preparation method thereof | |
| CN104207194A (en) | Digestible mutton slice and preparation method thereof | |
| CN105639220A (en) | Health-care nutritional powder | |
| CN104171839A (en) | Edible mushroom healthy flour and preparation method thereof | |
| CN107242544A (en) | Inonotus obliquus deer painstaking effort piece | |
| CN106490464A (en) | A kind of grain rice Hylotelephium erythrostictum (Miq.) H.Ohba formula food for safeguarding men's health | |
| CN107373639A (en) | A kind of special nasal feeding formula food of auxotype on the three of Patients with Cerebral Hemorrhage | |
| CN106418396A (en) | Healthcare food preparation | |
| CN104719715A (en) | Instant blood pressure lowering nutrition food production method | |
| CN104825585B (en) | Pure Chinese medicine healthy weight loss composition | |
| CN106578234A (en) | Memory function improving health tea preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180406 |